Cascadian Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cascadian Therapeutics, Inc.
CIK #0001412067
EDGAR Form CIK 2011 - 2023
10-K [0001412067]
10-Q [0001412067]
3 [0001412067]
4 [0001412067]
5 [0001412067]
8-K [0001412067]
D [0001412067]
SC 13D [0001412067]
SC 13G [0001412067]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Cascadian Therapeutics Inc [2018-02-01]
Biotechnology Value Fund L P Cascadian Therapeutics Inc [2017-02-02]
Growth Equity Opportunities IV LLC Cascadian Therapeutics Inc [2016-07-11]
Baupost Group LLC/MA Cascadian Therapeutics Inc [2016-07-08]
Franklin Resources Inc Oncothyreon Inc [2016-02-09]
Biotechnology Value Fund L P Oncothyreon Inc [2015-12-21]
BlackRock Inc Oncothyreon Inc [2015-02-02]
QVT Financial LP Oncothyreon Inc [2013-09-23]
Biotechnology Value Fund L P Oncothyreon Inc [2013-02-15]
BlackRock Inc Oncothyreon Inc [2013-01-30]
View All
Form 3/4/5 Subject 2011 - 2023
Cascadian Therapeutics, Inc.
Barris Peter J
James Steven P
Love Ted W
Fyfe Gwen A.
Eastland Julia Marie
Peterson Scott Robert
Azelby Robert
Spiegelman Daniel K
Myers Scott Dunseth
View All
Terms | Privacy | Guide
tony@aum13f.com